Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI

NCT07736261 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Poor Ovarian Reserve
Infertility (IVF Patients)

Interventions

DRUG: Drospirenone drug
DRUG: Cetrorelix 0.25 mg

Sponsor

Ahmed Saad